Registry for patients with cardiogenic shock at Inova Heart and Vascular Institute
Implementation of a Cardiogenic Shock Team and Clinical Outcomes (INOVA-SHOCK Registry)
This study looks at how well a special team helps patients with cardiogenic shock, including those with severe heart failure or heart attacks, by comparing survival rates and treatments before and after the team was formed in 2017.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Inova Health Care Services Academic / other |
| Locations | 1 site (Falls Church, Virginia) |
| Trial ID | NCT03378739 on ClinicalTrials.gov |
What this trial studies
This registry collects clinical outcomes related to patients experiencing cardiogenic shock, including those with acute decompensated heart failure and acute myocardial infarction. It aims to compare survival rates before and after the establishment of a dedicated Cardiogenic Shock team in 2017. The study will analyze the effectiveness of mechanical circulatory support interventions, such as ECMO and Impella, versus no circulatory intervention. Data will be gathered from patients treated at the Inova Heart and Vascular Institute, including both inpatients and those transferred from other facilities.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old with documented cardiogenic shock treated at the Inova Heart and Vascular Institute.
Not a fit: Patients under the age of 18 will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this registry could improve treatment protocols and outcomes for patients suffering from cardiogenic shock.
How similar studies have performed: Other studies have shown success in improving outcomes for cardiogenic shock patients through specialized treatment teams, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: -Patients at the IHVI with documented Cardiogenic Shock team intervention for acute decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic shock. Exclusion Criteria: -Patients under the age of 18 will be excluded.
Where this trial is running
Falls Church, Virginia
- Inova Fairfax Hospital — Falls Church, Virginia, United States (Recruiting)
Study contacts
- Principal investigator: Vanessa Blumer, MD — Inova Health Care Services
- Study coordinator: Bhruga Shah
- Email: bhruga.shah@inova.org
- Phone: 703-776-2828
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.